CG INVITES CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,435 KRW | -0.20% |
|
-4.70% | -12.25% |
| Sales 2022 | 38.64B 27.9M 2.33B | Sales 2023 | 4.88B 3.52M 294M | Capitalization | 208B 150M 12.55B |
|---|---|---|---|---|---|
| Net income 2022 | -23.87B -17.23M -1.44B | Net income 2023 | -48.92B -35.32M -2.95B | EV / Sales 2022 | 5.93 x |
| Net cash position 2022 | 11.83B 8.54M 713M | Net cash position 2023 | 12.29B 8.87M 740M | EV / Sales 2023 | 40.2 x |
| P/E ratio 2022 |
-10.1
x | P/E ratio 2023 |
-4.2
x | Employees | 68 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.55% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.20% | ||
| 1 week | -4.70% | ||
| 1 month | -18.83% | ||
| 3 months | -31.02% | ||
| 6 months | -6.35% | ||
| Current year | -12.25% |
1 week
2 425.00
2 625.00
1 month
2 350.003 170.00
Current year
2 350.004 385.00
1 year
2 350.005 400.00
3 years
2 350.008 730.00
5 years
2 350.0014 766.67
10 years
2 350.0019 794.87
| Managers | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 01/00/01 |
Young-Joon Yoo
AUD | Comptroller/Controller/Auditor | 52 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Joong-Myung Cho
CEO | Chief Executive Officer | 75 | 01/00/01 |
Jin-Woo Lee
BRD | Director/Board Member | 59 | 31/17/31 |
Kyung-Sook Cho
BRD | Director/Board Member | 64 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/24/31 | 2,435 | -0.20% | 51,555 |
| 30/24/30 | 2,440 | -2.01% | 63,294 |
| 29/24/29 | 2,490 | -3.86% | 131,203 |
| 28/24/28 | 2,590 | +1.97% | 181,203 |
| 27/24/27 | 2,540 | -0.59% | 108,341 |
End-of-day quote Korea S.E., May 31, 2024
More quotes
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.
Sector
Pharmaceuticals
Calendar
13/08/2024
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -12.25% | 135M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| -5.52% | 206B | |
| +6.17% | 164B | |
| -0.45% | 162B |
- Stock Market
- Equities
- A083790 Stock
